1-Methyl-1H-pyrrolo[2,3-b]pyridin-5-amine, 95.0%, 5g

(S)-3-(4-Fluorophenyl)morpholine hydrochloride, 97.0%, 100mg

6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine, 95%, 5g

Ethyl 3-Amino-3-methylbutyrate Hydrochloride>98.0%(N)5g

2-Amino-5,6-dihydro-4 H -cyclopenta[ b ]thiophene-3-carbonitrile, 95.0%, 2.5g

tert-Butyl ((3S,4R)-4-fluoropyrrolidin-3-yl)carbamate, 98%, 500mg

N -(4-Amino-2-methyl-phenyl)-acetamide, 95.0%, 5g

(S)-1-(1-Methyl-1H-pyrazol-4-yl)ethanamine dihydrochloride, 98%, 250mg

3-IODO-5-METHOXY-1H-INDAZOLE, 95%, 1g

GC capillary column ROTI®Cap-1701, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Dipotassium Dihydrogen Ethylenediaminetetraacetate Dihydrate>98.0%(T)25g

2-(4-Fluoro-1H-indol-1-yl)acetic acid, 95.0%, 1g

(S)-2-Amino-3-(4-methoxy-1H-indol-3-yl)propanoic acid, 95.0%, 1g